LataMed AI is trading 5.66% down at $0.25, with no new company-specific announcement or clearly identified catalyst found for September 18, 2026.
- The latest notable update was a September 9 cooperation agreement involving Venezuelan health ministries and a planned La Guaira deployment.
- Available coverage does not directly link that update to today’s decline; broader markets are modestly lower, while provided price history shows recent selling pressure.